文献速递心脑血管急症

冠状动脉CT血管成像与5年心肌梗死风险

Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
PubMed 文献 · N Engl J Med · 2018-08-25
一句话结论稳定胸痛患者在标准诊疗基础上加做冠状动脉CT血管成像,5年冠心病死亡或非致死性心肌梗死发生率低于单纯标准诊疗。

该开放标签、多中心、平行组试验将4146例因稳定胸痛转诊至心脏科门诊的患者随机分为标准诊疗加冠状动脉CT血管成像组(2073例)或单纯标准诊疗组(2073例),随访3至7年。中位随访4.8年,共20254患者年。CT血管成像组5年主要终点(冠心病死亡或非致死性心肌梗死)发生率为2.3%(48例),低于标准诊疗组的3.9%(81例),风险比0.59(95%CI 0.41至0.84,P=0.004)。两组5年侵入性冠状动脉造影和冠状动脉血运重建总发生率相似,但CT血管成像组启动更多预防性治疗和抗心绞痛治疗。心血管死亡、非心血管死亡及全因死亡发生率组间无显著差异。

要点

  • 稳定胸痛患者在标准诊疗基础上加做冠状动脉CT血管成像,5年冠心病死亡或非致死性心肌梗死发生率为2.3%(48例),低于单纯标准诊疗组的3.9%(81例),风险比0.59(95%CI 0.41至0.84,P=0.004)。
  • 5年侵入性冠状动脉造影在CT血管成像组491例、标准诊疗组502例,风险比1.00(95%CI 0.88至1.13),两组总发生率相似。
  • 5年冠状动脉血运重建在CT血管成像组279例、标准诊疗组267例,风险比1.07(95%CI 0.91至1.27),两组总发生率相似。
  • CT血管成像组启动更多预防性治疗(比值比1.40,95%CI 1.19至1.65)和更多抗心绞痛治疗(比值比1.27,95%CI 1.05至1.54)。
  • 心血管死亡、非心血管死亡及全因死亡发生率组间无显著差异。

适用人群与场景

  • 因稳定胸痛转诊至心脏科门诊评估的患者,共4146例,随机分为标准诊疗加冠状动脉CT血管成像组(2073例)或单纯标准诊疗组(2073例)。

研究设计与关键结果

  • 开放标签、多中心、平行组随机试验,纳入4146例稳定胸痛患者,随机分为标准诊疗加冠状动脉CT血管成像组(2073例)或单纯标准诊疗组(2073例),随访3至7年。
  • 中位随访4.8年,共20254患者年;5年主要终点(冠心病死亡或非致死性心肌梗死)发生率CT血管成像组2.3%(48例)vs 标准诊疗组3.9%(81例),风险比0.59(95%CI 0.41至0.84,P=0.004)。
  • 5年侵入性冠状动脉造影CT血管成像组491例 vs 标准诊疗组502例,风险比1.00(95%CI 0.88至1.13);冠状动脉血运重建CT血管成像组279例 vs 标准诊疗组267例,风险比1.07(95%CI 0.91至1.27)。
  • CT血管成像组启动更多预防性治疗(比值比1.40,95%CI 1.19至1.65)和更多抗心绞痛治疗(比值比1.27,95%CI 1.05至1.54)。
  • 心血管死亡、非心血管死亡及全因死亡发生率组间无显著差异。

证据类型、等级与局限

  • 证据类型:开放标签、多中心、平行组随机试验(SCOT-HEART,ClinicalTrials.gov NCT01149590)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在稳定胸痛患者的标准诊疗基础上加做冠状动脉CT血管成像,5年冠心病死亡或非致死性心肌梗死发生率显著低于单纯标准诊疗,且未导致冠状动脉造影或冠状动脉血运重建率显著升高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Although coronary computed tomographic angiography (CTA) improves diagnostic certainty in the assessment of patients with stable chest pain, its effect on 5-year clinical outcomes is unknown.

METHODS: In an open-label, multicenter, parallel-group trial, we randomly assigned 4146 patients with stable chest pain who had been referred to a cardiology clinic for evaluation to standard care plus CTA (2073 patients) or to standard care alone (2073 patients). Investigations, treatments, and clinical outcomes were assessed over 3 to 7 years of follow-up. The primary end point was death from coronary heart disease or nonfatal myocardial infarction at 5 years.

RESULTS: The median duration of follow-up was 4.8 years, which yielded 20,254 patient-years of follow-up. The 5-year rate of the primary end point was lower in the CTA group than in the standard-care group (2.3% [48 patients] vs. 3.9% [81 patients]; hazard ratio, 0.59; 95% confidence interval [CI], 0.41 to 0.84; P=0.004). Although the rates of invasive coronary angiography and coronary revascularization were higher in the CTA group than in the standard-care group in the first few months of follow-up, overall rates were similar at 5 years: invasive coronary angiography was performed in 491 patients in the CTA group and in 502 patients in the standard-care group (hazard ratio, 1.00; 95% CI, 0.88 to 1.13), and coronary revascularization was performed in 279 patients in the CTA group and in 267 in the standard-care group (hazard ratio, 1.07; 95% CI, 0.91 to 1.27). However, more preventive therapies were initiated in patients in the CTA group (odds ratio, 1.40; 95% CI, 1.19 to 1.65), as were more antianginal therapies (odds ratio, 1.27; 95% CI, 1.05 to 1.54). There were no significant between-group differences in the rates of cardiovascular or noncardiovascular deaths or deaths from any cause.

CONCLUSIONS: In this trial, the use of CTA in addition to standard care in patients with stable chest pain resulted in a significantly lower rate of death from coronary heart disease or nonfatal myocardial infarction at 5 years than standard care alone, without resulting in a significantly higher rate of coronary angiography or coronary revascularization. (Funded by the Scottish Government Chief Scientist Office and others; SCOT-HEART ClinicalTrials.gov number, NCT01149590 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Newby DE, Adamson PD, Berry C, et al. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018. PMID: 30145934. doi:10.1056/NEJMoa1805971

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。